Contraception for cancer survivors

Eleanor Schwarz, Rachel Hess, James Trussell

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations


Women who have survived cancer may need guidance in choosing a method of contraception. This paper reviews the evidence supporting the safety and efficacy of available methods of contraception for cancer survivors and concludes that the Copper T380A intrauterine device (IUD), a highly effective, reversible, long-acting, hormone-free method should be considered a first-line contraceptive option for women with a history of a hormonally mediated cancer. However, the levonorgestrel-containing IUD may be preferable for women being treated with tamoxifen and women who have survived non-hormonally mediated cancers. Women with IUDs can undergo all forms of imaging, including computed tomography and magnetic resonance imaging.

Original languageEnglish (US)
JournalJournal of General Internal Medicine
Issue numberSUPPL. 2
StatePublished - Nov 1 2009
Externally publishedYes


  • Cancer survivors
  • Contraception

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Contraception for cancer survivors'. Together they form a unique fingerprint.

Cite this